Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 7/3/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 12/2/25 | Sell | Chief Technology Officer | 3,104,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| -2.11% | -1.68% | +43.40% | +95.58% | 66.93B | |
| +1.29% | -0.48% | +35.61% | +76.28% | 61.97B | |
| +1.67% | +2.47% | -11.32% | +392.05% | 28.26B | |
| +4.43% | +1.24% | +26.36% | +17.14% | 24.59B | |
| +0.34% | -6.78% | -0.01% | -14.59% | 24.3B | |
| +0.48% | -1.77% | +18.21% | -22.40% | 19.41B | |
| -3.03% | -2.29% | +181.72% | +333.47% | 16.77B | |
| +2.92% | -2.41% | -5.97% | +543.71% | 14.18B | |
| +3.24% | -0.31% | -7.34% | +833.51% | 14B | |
| Average | +0.95% | -2.95% | +31.18% | +250.53% | 30.05B | |
| Weighted average by Cap. | +0.56% | -2.83% | +32.00% | +173.10% |
Employees
6
